Progyny, Inc. (PGNY) financial statements and ratios from SEC XBRL: revenue $1.29B (latest fiscal year), net margin 4.5%, revenue growth 5.3% YoY, P/E 25.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.29B |
| Net Margin | 4.5% |
| Revenue Growth (YoY) | 5.3% |
| EPS Growth (YoY) | 80.0% |
| FCF Growth (YoY) | -12.0% |
| P/E Ratio | 25.2 |
| EV / EBITDA | 15.5 |
| Price / Book | 4.37 |
| Price / Sales | 1.51 |
| FCF Yield | 9.0% |
| Altman Z-Score | 8.67 (safe) |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
PGNY overview · PGNY earnings · PGNY KPIs · PGNY documents · PGNY ownership · PGNY peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.